The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology ... It has development and commercialization agreement for three of Daiichi Sankyo’s deruxtecan ADC ...

A subcutaneous version of Daiichi Sankyo’s AstraZeneca-partnered blockbuster antibody-drug conjugate (ADC) Enhertu could be ...

Q2 2025 Earnings Conference Call October 31, 2024 2:30 AM ET. Company Participants. Hiroyuki Okuzawa - Representative Director, Presi ...

Narrow-moat Daiichi Sankyo is a Japanese drugmaker with a global footprint and cutting-edge development platform for antibody drug conjugates. As an established pharmaceutical company with a long ...

Additionally, at the Altkirch facility in France, Daiichi Sankyo manufactures the active substances used in its traditional pharmaceutical products under the Luitpold brand, which is also owned by ...

Bernstein analyst Miki Sogi assigned a Buy rating to Daiichi Sankyo Company (DSKYF – Research Report) today and set a price target of ...

New Delhi, The Delhi High Court on Tuesday ordered auctioning of the Fortis trademark in connection with the ₹3,500 crore arbitral award passed in favour of Japanese pharma major Daiichi Sankyo ...

Here’s how it works. The best over-ear headphones deliver a fully immersive audio experience, perfect for those who crave high-quality sound. Tailored for audio enthusiasts, these headphones ...

When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. Over-ear headphones are the kings of music listening. Sure, in-ear earbuds are great for carrying ...

He covers the gamut of gadgets and is a notable reviewer of mobile accessories and portable audio products, including headphones and speakers. He's also an e-reader and e-publishing expert as well ...